Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

BUY
$263.81 - $337.27 $97,873 - $125,127
371 New
371 $98,000
Q2 2022

Jul 26, 2022

SELL
$301.4 - $428.42 $39,483 - $56,123
-131 Closed
0 $0
Q1 2022

Apr 27, 2022

SELL
$379.46 - $424.54 $11,383 - $12,736
-30 Reduced 18.63%
131 $55,000
Q4 2021

Jan 31, 2022

SELL
$373.53 - $434.12 $87,032 - $101,149
-233 Reduced 59.14%
161 $67,000
Q3 2021

Nov 03, 2021

SELL
$396.76 - $455.92 $508,646 - $584,489
-1,282 Reduced 76.49%
394 $163,000
Q2 2021

Jul 30, 2021

BUY
$372.36 - $412.07 $624,075 - $690,629
1,676 New
1,676 $664,000
Q1 2020

Apr 29, 2020

SELL
$243.44 - $359.98 $867,620 - $1.28 Million
-3,564 Closed
0 $0
Q4 2019

Jan 27, 2020

BUY
$281.18 - $322.05 $699,294 - $800,938
2,487 Added 230.92%
3,564 $1.15 Million
Q3 2019

Oct 28, 2019

SELL
$294.25 - $341.49 $272,475 - $316,219
-926 Reduced 46.23%
1,077 $320,000
Q2 2019

Jul 30, 2019

SELL
$279.29 - $336.89 $729,505 - $879,956
-2,612 Reduced 56.6%
2,003 $675,000
Q1 2019

Apr 30, 2019

BUY
$246.18 - $297.25 $919,236 - $1.11 Million
3,734 Added 423.84%
4,615 $1.37 Million
Q4 2018

Feb 01, 2019

BUY
$232.7 - $281.66 $8,609 - $10,421
37 Added 4.38%
881 $224,000
Q3 2018

Nov 05, 2018

SELL
$236.3 - $277.15 $66,400 - $77,879
-281 Reduced 24.98%
844 $234,000
Q2 2018

Jul 30, 2018

BUY
$217.98 - $237.23 $127,300 - $138,542
584 Added 107.95%
1,125 $265,000
Q1 2018

May 02, 2018

SELL
$218.74 - $251.43 $6.22 Million - $7.15 Million
-28,419 Reduced 98.13%
541 $124,000
Q4 2017

Jan 31, 2018

BUY
$217.88 - $244.43 $4.02 Million - $4.51 Million
18,442 Added 175.34%
28,960 $6.31 Million
Q3 2017

Oct 31, 2017

BUY
$231.6 - $253.39 $2.44 Million - $2.67 Million
10,518
10,518 $2.49 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.